EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeit

Isolated Tricuspid Valve Surgery for Functional Tricuspid Regurgitation

Daisuke Kaneyuki iD, Andrew M Jordan, Jake L Rosen, Thomas Reese Macmillan, Rohinton J Morris, Vakhtang Tchantchaleishvili

The Thoracic and Cardiovascular Surgeon · 01.03.2025 · 73 (02) · 111-116

DOI: 10.1055/a-2300-6791 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift The Thoracic and Cardiovascular Surgeon, erschienen am 01.03.2025. Verfasst von Daisuke Kaneyuki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Tricuspid Valve, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe tricuspid regurgitation (TR) adversely affects long-term survival; however, isolated tricuspid valve (TV) surgery has been rarely performed due to high operative mortality. In addition, the previous literature included heterogeneous TR etiologies. Therefore, we aimed to elucidate early and long-term outcomes of isolated TV surgery for functional TR.

Methods

An electronic search was performed to identify all relevant studies. Baseline characteristics, perioperative variables, and clinical outcomes were extracted and pooled for meta-analysis.

Results

This meta-analysis included seven studies. Pooled analyses showed that 68% (35, 89) of patients had preoperative atrial fibrillation or flutter, and 58% (11, 94) had a history of left-sided valve surgery. Seventy-three percent (65, 80) of patients had at least one physical exam finding of right-sided heart failure, and 57% (44, 69) were in New York Heart Association class III or IV. TV replacement was more common than repair. In TV replacement, bioprosthetic valve (39%, 13, 74) was more common than mechanical prosthesis (22%, 18, 26). The early mortality rate was 7%. Twenty percent of patients required a permanent pacemaker postoperatively. The overall 1- and 5-year survival rates were 84.5 and 69.1%, respectively.

Conclusion

More than half of the patients who underwent isolated TV surgery for functional TR had undergone left-sided valve surgery and had significant heart failure symptoms at the time of surgery. Further studies on the surgical indication for concomitant TV surgery at the time of left-sided valve surgery and the appropriate timing of surgery for isolated functional TR are needed to improve survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tricuspid Valve InsufficiencyTricuspid ValveHeart Valve Prosthesis ImplantationHumansTreatment OutcomeRisk FactorsTime FactorsHeart Valve ProsthesisMaleFemaleMiddle AgedPostoperative ComplicationsAgedBioprosthesisSeverity of Illness IndexRecovery of Function

Autor:innen und Institutionen

  • Division of Cardiac Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States.

ORCID-Profile: Daisuke Kaneyuki

Zitieren

APA

Kaneyuki, D., Jordan, A. M., Rosen, J. L., Macmillan, T. R., Morris, R. J., & Tchantchaleishvili, V. (2025). Isolated Tricuspid Valve Surgery for Functional Tricuspid Regurgitation. The Thoracic and Cardiovascular Surgeon, 73(02), 111-116. https://doi.org/10.1055/a-2300-6791

Vancouver

Kaneyuki D, Jordan AM, Rosen JL, Macmillan TR, Morris RJ, Tchantchaleishvili V. Isolated Tricuspid Valve Surgery for Functional Tricuspid Regurgitation. The Thoracic and Cardiovascular Surgeon. 2025;73(02):111-116. doi:10.1055/a-2300-6791

BibTeX
@article{Kaneyuki2025,
  author = {Kaneyuki, Daisuke and Jordan, Andrew M and Rosen, Jake L and Macmillan, Thomas Reese and Morris, Rohinton J and Tchantchaleishvili, Vakhtang},
  title = {Isolated Tricuspid Valve Surgery for Functional Tricuspid Regurgitation},
  journal = {The Thoracic and Cardiovascular Surgeon},
  year = {2025},
  volume = {73},
  number = {02},
  pages = {111--116},
  doi = {10.1055/a-2300-6791}
}
Kostenlos starten →